 NESS ZIONA, Israel--BUSINESS WIRE--BiomX Inc. NYSE American: PHGE, a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer, will participate in two upcoming virtual investor conferences. Presentation Details: Event: Chardans 3rd Annual Microbiome Medicines Summit Date: Monday, March 8, 2021 Time: 10:45 AM EST Event: H.C. Wainwright Global Life Sciences Conference 